GSKH vs. FTXH

Last updated Jun 6, 2026

GSKH (GSK plc ADRhedged ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Health & Biotech Equities funds - GSKH tracks the GSK plc Local Shares Total Return while FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past year, GSKH returned 30.78% vs 40.73% for FTXH. A 0.59 correlation means they provide meaningful diversification when combined. GSKH charges 0.19%/yr vs 0.60%/yr for FTXH.

Performance

GSKH vs. FTXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GSK plc ADRhedged ETF (GSKH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with GSKH having a 7.84% return and FTXH slightly lower at 7.78%.

GSKH

• 1D: 1.34%
• 1M: 4.57%
• YTD: 7.84%
• 6M: 8.19%
• 1Y: 30.78%
• 3Y*: —
• 5Y*: —
• 10Y*: —

FTXH

• 1D: 0.15%
• 1M: 2.45%
• YTD: 7.78%
• 6M: 9.56%
• 1Y: 40.73%
• 3Y*: 12.54%
• 5Y*: 8.37%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GSKH vs. FTXH - Yearly Performance Comparison

	2026 (YTD)	2025
GSKH GSK plc ADRhedged ETF	7.84%	37.05%
FTXH First Trust Nasdaq Pharmaceuticals ETF	7.78%	22.90%

Correlation

The correlation between GSKH and FTXH is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.60
Correlation (All Time) Calculated using the full available price history since Jan 8, 2025	0.59

The correlation between GSKH and FTXH has been stable across timeframes, ranging from 0.59 to 0.60 - a consistent structural relationship.

GSKH vs. FTXH - Sectors Allocation Comparison

Sectors	GSKH	FTXH
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

GSKH vs. FTXH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GSKH

GSKH Risk / Return Rank: 36
GSKH Sharpe Ratio Rank: 36
GSKH Sortino Ratio Rank: 39
GSKH Omega Ratio Rank: 38
GSKH Calmar Ratio Rank: 37
GSKH Martin Ratio Rank: 30

FTXH

FTXH Risk / Return Rank: 81
FTXH Sharpe Ratio Rank: 78
FTXH Sortino Ratio Rank: 82
FTXH Omega Ratio Rank: 73
FTXH Calmar Ratio Rank: 91
FTXH Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GSKH vs. FTXH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GSKH	FTXH	Difference
Sharpe ratio: Return per unit of total volatility	1.18	2.39	-1.21
Sortino ratio: Return per unit of downside risk	1.82	3.49	-1.66
Omega ratio: Gain probability vs. loss probability	1.23	1.41	-0.18
Calmar ratio: Return relative to maximum drawdown	1.67	5.48	-3.81
Martin ratio: Return relative to average drawdown	4.06	15.81	-11.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GSKH vs. FTXH - Sharpe Ratio Comparison

The current GSKH Sharpe Ratio is 1.18, which is lower than the FTXH Sharpe Ratio of 2.39. The chart below compares the historical Sharpe Ratios of GSKH and FTXH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GSKH	FTXH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.18	2.39	-1.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.51	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.19	0.39	+0.80

Drawdowns

GSKH vs. FTXH - Drawdown Comparison

The maximum GSKH drawdown since its inception was -18.54%, smaller than the maximum FTXH drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for GSKH and FTXH.

Drawdown Indicators

	GSKH	FTXH	Difference
Max Drawdown Largest peak-to-trough decline	-18.54%	-32.11%	+13.57%
Max Drawdown (1Y) Largest decline over 1 year	-18.54%	-7.47%	-11.07%
Max Drawdown (3Y) Largest decline over 3 years	—	-19.51%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-19.51%	—
Current Drawdown Current decline from peak	-13.28%	-0.31%	-12.97%
Average Drawdown Average peak-to-trough decline	-5.65%	-5.83%	+0.18%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.61%	2.58%	+5.03%

Volatility

GSKH vs. FTXH - Volatility Comparison

GSK plc ADRhedged ETF (GSKH) has a higher volatility of 6.33% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 5.25%. This indicates that GSKH's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GSKH	FTXH	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.33%	5.25%	+1.08%
Volatility (6M) Calculated over the trailing 6-month period	18.35%	11.91%	+6.44%
Volatility (1Y) Calculated over the trailing 1-year period	26.30%	17.14%	+9.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.08%	16.34%	+10.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.08%	18.42%	+8.66%

GSKH vs. FTXH - Expense Ratio Comparison

GSKH has a 0.19% expense ratio, which is lower than FTXH's 0.60% expense ratio.

Dividends

GSKH vs. FTXH - Dividend Comparison

GSKH's dividend yield for the trailing twelve months is around 1.57%, more than FTXH's 1.19% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
FTXH First Trust Nasdaq Pharmaceuticals ETF	1.19%	1.41%	1.66%	1.55%	1.11%	1.03%	0.82%	0.67%	0.91%	2.18%	0.19%
GSKH GSK plc ADRhedged ETF	1.57%	1.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both GSKH and FTXH in my portfolio?

GSKH and FTXH have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GSKH or FTXH?

GSKH has higher volatility (6.33%) compared to FTXH (5.25%). In terms of maximum drawdown, GSKH dropped -18.54% vs FTXH's -32.11%.

Which ETF is better, GSKH or FTXH?

On 1-year performance, FTXH leads with 40.73% vs 30.78% for GSKH. On fees, GSKH is cheaper at 0.19% per year. On volatility, FTXH has been the lower-risk option at 5.25%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GSKH or FTXH?

Over the 1-year period, FTXH has performed better with a 40.73% return vs 30.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GSKH or FTXH?

GSKH is cheaper with a 0.19% expense ratio, compared with 0.60% for FTXH.

Which ETF pays a higher dividend yield, GSKH or FTXH?

GSKH has the higher dividend yield at 1.57%, compared with 1.19% for FTXH.

What is the main difference between GSKH and FTXH?

GSKH tracks GSK plc Local Shares Total Return, while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: ADRhedged and First Trust. Their fees differ too: 0.19% for GSKH and 0.60% for FTXH.

Which has better risk-adjusted returns?

FTXH currently has the higher Sharpe Ratio (2.39 vs 1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.